Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors.
Yoriko Yamashita-KashimaKeigo YorozuTakaaki FujimuraNatsumi KawasakiMitsue KurasawaShigeki YoshiuraNaoki HaradaOsamu KondohYasushi YoshimuraPublished in: International journal of hematology (2022)
Coadministration of bendamustine in obinutuzumab retreatment may be effective against obinutuzumab-resistant tumors.
Keyphrases